NEW YORK (Reuters Health)—A large epidemiological study provides more evidence of a link between tumor necrosis factor inhibitors (TNFi) and peripheral neuropathy (PN). “These events are rare and the benefit of these drugs still outweigh this risk so this should not change practice,” cautions first author Dr. Mahyar Etminan from the University of British Columbia…
EULAR 2013: Tips for Managing Peripheral Neuropathy in Rheumatic Disease
How to determine which tests to order, how to interpret them, and how to decide on the right treatment course